Document:

Exhibit 10.1

 

Asset Purchase
Agreement

 

THIS made as of the 1st day of December, 2020.

 

AMONG:

 

warpspeed
taxi inc., a company incorporated pursuant to the laws of Wyoming with an office located at 9436 W. Lake Mead Blvd,
Las Vegas, NV 89134;

 

(the “Purchaser”)

 

		AND:	LIMITLESS PROJECTS INC., a company incorporated pursuant to the laws
of Wyoming with an office located at 420 North Nellis A3-146, Las Vegas, Nevada, 89110;

 

(the “Vendor”) 

 

A.       The
Vendor owns a 100% undivided interest in and to a certain ride-hailing and food delivery computer and mobile device application
including, without limitation, the application, all software, the corresponding website domain, content, data, and all incorporated
technology (the “Application”); and

 

B.       The
Purchaser wishes to acquire and the Vendor wishes to sell, transfer, and deliver, on the terms and conditions set forth in this
Agreement, all of Vendor’s right, title and interest in and to the Application, free and clear of all Encumbrances (as defined
below), and subject to the Vendor completing a working prototype of the Application acceptable to the Purchaser; and

 

In consideration of the undertakings of the
parties, their mutual promises and covenants, and other valuable consideration as provided, the parties, intending to be legally
bound, hereby agree as follows:

 

Article 1–
INTERPRETATION

 

		1.1	Definitions

 

In this Agreement, the following terms and
expressions will have the following meanings:

 

		(a)	“Accrued Interest” shall mean simple interest at an annual rate of 5% that shall
accrue on the Note;

 

		(b)	“Agreement” means this asset purchase agreement and all instruments amending it;
“hereof“, “hereto” and “hereunder” and similar expressions mean and refer to
this Agreement and not to any particular Article, Section, or other subdivision; “Article”, “Section”
or other subdivisions of this Agreement followed by a number means and refers to the specified Article, Section or other subdivision
of this Agreement;

 

		(c)	“Application” means, collectively the full commercial version of the WarpSpeed
Taxi computer and mobile device application, including, without limitation, the domain name www.warpspeedtaxi.com; the current
website and application front-end and back-end content and software; all related intellectual property rights, logos, customer
lists and agreements, email lists, passwords, and usernames and trade names; and all incorporated technology, together with all
Trade Secrets, and any and all improvements, corrections, modifications, updates, enhancements or other changes, whether or not
included in the current commercial version, plus all System Documentation;

 

    1

     

    

 

		(d)	“Business Day” means any day other than a Saturday, a Sunday or a statutory holiday
in the State of Wyoming;

 

		(e)	“Closing” means the completion of the Transaction pursuant to this Agreement at
the Closing Time;

 

		(f)	“Closing Date” means on or before December 31, 2020, or such other date agreed
to by the parties;

 

		(g)	“Closing Time” means 10:00 am in the City of Cheyenne, Wyoming on the Closing
Date or such other time on the Closing Date as the Parties may agree upon as the time at which the Closing shall take place;

 

		(h)	“Completion Date” has the meaning ascribed in Section 6.3.

 

		(i)	“Consent” means a license, permit, approval, consent, certificate, registration
or authorization (including, without limitation, those made or issued by a Regulatory Authority, in respect of a Contract, or otherwise);

 

		(j)	“Contract” means any agreement, understanding, indenture, contract, lease, deed
of trust, license, option, instrument or other commitment, whether written of oral;

 

		(k)	“Dispute” shall have the meaning ascribed in Section 8.1;

 

		(l)	“Encumbrances” means mortgages, charges, pledges, security interests, liens, encumbrances,
actions, claims, demands and equities of any nature whatsoever or howsoever arising and any rights or privileges capable of becoming
any of the foregoing;

 

		(m)	“Law” or “Laws” means all requirements imposed by statutes, regulations,
rules, ordinances, by-laws, decrees, codes, policies, judgments, orders, rulings, decisions, approvals, notices, permits, guidelines
or directives of any Regulatory Authority;

 

		(n)	“Loss” and “Losses” mean any and all demands, claims, actions
or causes of action, assessments, losses, damages, liabilities, costs, and expenses, including without limitation, interest, penalties,
fines and reasonable attorneys, accountants and other professional fees and expenses, but excluding damages for lost profits or
lost business opportunities and excluding any indirect, consequential or punitive damages suffered by the Purchaser or the Vendor;

 

		(o)	“Note” shall have the meaning ascribed in Section 2.1(c);

 

		(p)	“Patents” means any United States, Canadian or foreign patents and applications
(including provisional applications), patents issuing from such applications, certificates of invention or any other grants by
any court, administrative agency or commission or other federal, state, provincial, county, local or foreign governmental authority,
instrumentality, agency commission or subdivision thereof, including the U.S. Patent and Trademark Office, Canadian Intellectual
Property Office and the European Patent Office, for the protection of inventions, or foreign equivalents of any of the foregoing;

 

    2

     

    

 

		(q)	“Parties” means the Vendor and the Purchaser and any other person that may become
a party to this Agreement, and Party means any one of them;

 

		(r)	“person” includes any individual, corporation, partnership, firm, joint venture,
syndicate, association, trust, government, governmental agency and any other form of entity or organization;

 

		(s)	“Regulatory Authority” means any government, regulatory or administrative authority,
agency, commission, utility or board (federal, state, municipal or local, domestic or foreign) having jurisdiction in the relevant
circumstances and any person acting under the authority of any of the foregoing and any judicial, administrative or arbitral court,
authority, tribunal or commission having jurisdiction in the relevant circumstances;

 

		(t)	“System Documentation” means all documentation used in the development and updating
of the Application, including but not limited to, design or development specifications, and related correspondence and memoranda;
and

 

		(u)	“Trade Secret” means any scientific or technical information, design, process,
procedure, formula, or improvement included in the Application that is valuable, not generally known in the industry, and gives
the owner of the Application a competitive advantage over those competitors who do not know or use such information;

 

		(v)	“Transaction” means the purchase and sale of the Application and all other transactions
contemplated by this Agreement, including the execution of the Note; and

 

		(w)	“Valuation” shall have the meaning ascribed in Section 2.1(c).

 

		1.2	Best Knowledge

 

Any reference herein to “the best knowledge”
of the Vendor will be deemed to mean the actual knowledge of the directors of the Vendor, together with the knowledge which they
would have had if they had conducted a diligent inquiry into the relevant subject matter.

 

		1.3	Currency

 

Unless otherwise indicated, all references
to dollar amounts in this Agreement are expressed in United States currency.

 

		1.4	Governing Law

 

This Agreement shall be exclusively governed
by and construed and interpreted in accordance with the laws of the State of Wyoming and the federal laws of the United States
applicable therein. The Parties hereby irrevocably attorn to the exclusive jurisdiction of the courts of Wyoming with respect to
any matter arising under or related to this Agreement.

 

		1.5	Interpretation Not Affected by Headings

 

The division of this Agreement into articles
and sections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation
of this Agreement.

 

    3

     

    

 

		1.6	Number and Gender

 

In this Agreement, unless the context otherwise
requires, any reference to gender shall include both genders and words importing the singular number shall include the plural and
vice-versa.

 

		1.7	Time of Essence

 

Time shall be of the essence of every provision
of this Agreement.

 

		1.8	Severability

 

Each of the provisions contained in this Agreement
is distinct and severable and a declaration of invalidity or unenforceability of any such provision or part thereof by a court
of competent jurisdiction shall not affect the validity or enforceability of any other provision hereof.

 

		1.9	Calculation of Time Periods

 

Where a time period is expressed to begin or
end at, on or with a specified day, or to continue to or until a specified day, the time period includes that day. Where a time
period is expressed to begin after or to be from a specified day, the time period does not include that day. Where anything is
to be done within a time period expressed after, from or before a specified day, the time period does not include that day. If
the last day of a time period is not a Business Day, the time period shall end on the next Business Day.

 

		1.10	Statutory Instruments

 

Unless otherwise specifically provided in this
Agreement, any reference in this Agreement to any Law shall be construed as a reference to such Law as amended or re-enacted from
time to time or as a reference to any successor thereto.

 

Article 2–
PURCHASE AND SALE

 

		2.1	Purchase and Sale of Application

 

On the terms and subject to the fulfilment
of the conditions of this Agreement, the Vendor agrees to sell, assign and transfer to the Purchaser, and the Purchaser agrees
to purchase from the Vendor at the Closing Time on the Closing Date, the Application in consideration of the Purchaser:

 

		(a)	paying $10,000 to the Vendor upon execution of this Agreement;

 

		(b)	paying an additional $40,000 to the Vendor upon the Vendor’s delivery of a working prototype
of the Application to the Purchaser in a form acceptable to the Purchaser; and

 

		(c)	issuing a promissory note (the “Note”) to the Vendor for an amount equal to the estimation
of value of the Application and the Purchaser’s joint ownership interest in related data and databases based on an independent
business valuation completed by a valuator who is accredited by the American Society of Appraisers and acceptable to both parties
(the “Valuation”) less the $50,000 in cash payments made in accordance with Sections 2.1(a) and (b). Notwithstanding
the Valuation’s estimation of value of the Application, the amount of the Note shall not be less than $50,000 and shall not
exceed $250,000. The Note shall bear simple interest at a rate of 5% per annum and all principal and accrued interest shall be
payable in full and on demand provided that the Vendor’s demand shall not be made until a date that is at least three years
from the date of the Valuation.

 

    4

     

    

 

		2.2	Operational Data and Databases

 

All operational data and databases relating
to the Application shall be jointly owned by the Purchaser and Vendor. Notwithstanding this joint ownership of the data and databases,
the Vendor shall not be entitled to use the data for any purpose that competes directly or indirectly with the Purchaser’s
use and operation of the Application for ride-hailing and food delivery.

 

		2.3	Transfer Taxes

 

The Purchaser shall be liable for and shall
pay all federal and provincial sales taxes and all other taxes, duties, fees or other like charges of any jurisdiction properly
payable in connection with the transfer of the Application by the Vendor to the Purchaser.

 

Article 3–
REPRESENTATIONS AND WARRANTIES

 

		3.1	Representations and Warranties of the Vendor

 

The Vendor hereby makes the following representations
and warranties to the Purchaser and acknowledges that the Purchaser is relying on such representations and warranties in entering
into this Agreement and completing the Transaction:

 

(1)       Incorporation
and Existence of the Vendor. The Vendor is a corporation incorporated and existing under the laws of the state of Wyoming.

 

(2)       Corporate
Power. The Vendor has the corporate power and authority to own or lease its property and to carry on its business as now being
conducted by it.

 

(3)       Options.
Except for the Purchaser’s right in this Agreement, no person has any option, warrant, right, call, commitment, conversion
right, right of exchange or other agreement or any right or privilege (whether by law, pre-emptive or contractual) capable of becoming
an option, commitment, conversion right, right of exchange or other agreement for the purchase from the Vendor of the Application,
or any license or similar right with respect to the Application.

 

(4)       Intellectual
Property Rights. To the best knowledge of the Vendor, the Application does not in any respect infringe the right of any person
under or in respect of any patent, design, trade mark, trade name, copyright or other industrial or intellectual property.

 

(5)       Validity
of Agreement.

 

		(a)	The Vendor has all necessary corporate power to own the Application and to enter into and perform
its obligations under this Agreement, and the Vendor has all necessary corporate power to enter into and perform its obligations
under any other agreements or instruments to be delivered or given by it pursuant to this Agreement.

 

		(b)	The Vendor’s execution and delivery of, and performance of its obligations under, this Agreement
and the consummation of the Transaction have been duly authorized by all necessary corporate action on the part of the Vendor.

 

		(c)	This Agreement or any other agreements entered into pursuant to this Agreement to which the Vendor
is a party constitute legal, valid and binding obligations of the Vendor enforceable against it in accordance with their respective
terms, except as enforcement may be limited by bankruptcy, insolvency and other laws affecting the rights of creditors generally
and except that equitable remedies may be granted only in the discretion of a court of competent jurisdiction.

 

    5

     

    

 

(6)       No
Violation. The execution and delivery of this Agreement by the Vendor, the consummation of the Transaction and the fulfilment
by the Vendor of the terms, conditions and provisions hereof will not (with or without the giving of notice or lapse of time, or
both):

 

		(a)	contravene or violate or result in a material breach or a material default under or give rise to
a right of termination, amendment or cancellation or the acceleration of any obligations of the Vendor under:

 

		(i)	any applicable Law;

 

		(ii)	any judgment, order, writ, injunction or decree of any Regulatory Authority having jurisdiction
over the Vendor;

 

		(iii)	its Articles of Incorporation or any resolutions of the board of directors or shareholders of the
Vendor;

 

		(iv)	any Consent held by the Vendor or necessary to the ownership of the Application; or

 

		(v)	the provisions of any Contract to which the Vendor is a party or by which it is, or any of its
properties or assets are, bound; or

 

		(b)	result in the creation or imposition of any Encumbrance on any of the Application.

 

(7)       Regulatory
and Contractual Consents. To the knowledge of the Vendor, there is no requirement to make any filing with, give any notice
to or obtain any Consent from any Regulatory Authority as a condition to the lawful consummation of the Transaction. There is no
requirement under any Contract to which the Vendor is a party or by which the Vendor is bound to make any filing with, give any
notice to, or to obtain the Consent of, any party to such Contract relating to the Transaction.

 

(8)       Compliance
with Laws. The Vendor has complied, in all material respects, with all Laws applicable to the Application.

 

(9)       Full
Disclosure. No representation or warranty by the Vendor in this Agreement and no statement contained in any certificate or
other document furnished or to be furnished to the Purchaser pursuant to this Agreement contains any untrue statement of a material
fact, or omits to state a material fact necessary to make the statements contained therein, in light of the circumstances in which
they are made, not misleading.

 

		3.2	Representations and Warranties of the Purchaser

 

The Purchaser hereby makes the following representations
and warranties to the Vendor and acknowledges that the Vendor is relying on such representations and warranties in entering into
this Agreement and completing the Transaction:

 

(1)       Incorporation
and Existence. The Purchaser has been duly incorporated and organized and is a valid and subsisting company under the laws
of the State of Wyoming, and is duly qualified to carry on business in the State of Wyoming and in each other jurisdiction, if
any, wherein the carrying out of the activities contemplated makes such qualifications necessary.

 

(2)       Validity
of Agreement.

 

		(a)	The Purchaser has all necessary corporate power to own the Application. The Purchaser has all necessary
corporate power to enter into and perform its obligations under this Agreement and any other agreements or instruments to be delivered
or given by it pursuant to this Agreement.

 

    6

     

    

 

		(b)	The execution, delivery and performance by the Purchaser of this Agreement and the consummation
of the Transaction have been duly authorized by all necessary corporate action on the part of the Purchaser.

 

		(c)	This Agreement or any other agreements entered into pursuant to this Agreement to which the Purchaser
is a party constitute legal, valid and binding obligations of the Purchaser, enforceable against the Purchaser in accordance with
their respective terms, except as enforcement may be limited by bankruptcy, insolvency and other laws affecting the rights of creditors
generally and except that equitable remedies may be granted only in the discretion of a court of competent jurisdiction.

 

(3)       No
Violation. The execution and delivery of this Agreement by the Purchaser, the consummation of the Transaction and the fulfilment
by the Purchaser of the terms, conditions and provisions hereof will not (with or without the giving of notice or lapse of time,
or both):

 

		(a)	contravene or violate or result in a breach or a default under or give rise to a right of termination,
amendment or cancellation or the acceleration of any obligations of the Purchaser, under:

 

		(i)	any applicable Law;

 

		(ii)	any judgment, order, writ, injunction or decree of any Regulatory Authority having jurisdiction
over the Purchaser;

 

		(iii)	the Articles of Incorporation, or any resolutions of the board of directors or shareholders of
the Purchaser;

 

		(iv)	any Consent held by the Purchaser; or

 

		(v)	the provisions of any Contract to which the Purchaser is a party or by which it is, or any of its
properties or assets are, bound.

 

(4)       Brokers.
The Purchaser has not engaged any broker or other agent in connection with the Transaction and, accordingly, there is no commission,
fee or other remuneration payable to any broker or agent who purports or may purport to have acted for the Purchaser.

 

(5)       Consents.
There is no requirement for the Purchaser to make any filing with, give any notice to or obtain any Consent from any Regulatory
Authority as a condition to the lawful consummation of the Transaction.

 

		3.3	Survival of Covenants, Representations and Warranties of the Vendor

 

To the extent that they have not been fully
performed at or prior to the Closing Time, and unless otherwise provided, the covenants, representations and warranties of the
Vendor contained in this Agreement and any agreement, instrument, certificate or other document executed or delivered pursuant
to this Agreement shall survive the Closing and shall continue for the benefit of the Purchaser for a period of two years notwithstanding
such Closing, nor any investigation made by or on behalf of the Purchaser or any knowledge of the Purchaser, except that the representations
and warranties set out in Section 3.1(1) to and including 3.1(4) and the corresponding representations and warranties set out in
the certificates to be delivered pursuant to Section 6.1, shall survive the Closing and continue in full force and effect without
limitation of time.

 

    7

     

    

 

		3.4	Survival of Covenants, Representations and Warranties of the Purchaser

 

To the extent that they have not been fully
performed at or prior to the Closing Time, and unless otherwise provided, the covenants, representations and warranties of the
Purchaser contained in this Agreement and in any agreement, instrument, certificate or other document delivered pursuant to this
Agreement shall survive the Closing and shall continue for the benefit of the Vendor for a period of two years notwithstanding
such Closing, nor any investigation made by or on behalf of the Vendor or any knowledge of the Vendor, except that the representations
and warranties set out in Sections 3.2(1) and 3.2(4), and the corresponding representations and warranties set out in the certificates
to be delivered pursuant to Section 6.2, shall survive the Closing and shall continue in full force and effect without limitation
of time.

 

Article 4–
COVENANTS

 

		4.1	Maintenance of Corporate Status

 

Prior to Closing and for
a period of a least 36 months after the Closing Date, the Purchaser and Vendor shall each use their commercially reasonable efforts
to remain a corporation validly subsisting under the laws of its jurisdiction of existence, licensed, registered or qualified as
a foreign corporation in all jurisdictions where the character of its properties owned or leased or the nature of the activities
conducted by it make such licensing, registration or qualification necessary and shall carry on its business in the ordinary course
and in compliance in all material respects with all applicable laws, rules and regulations of each such jurisdiction.

 

		4.2	Due Diligence Review

 

The Vendor shall make available
to the Purchaser upon execution of this Agreement any and all files, documents, records or other information in its possession
relating to the Application that may be of use to the Purchaser in conducting a due diligence review. The Vendor shall also use
their best efforts to obtain for the Purchaser such additional other records or information as reasonably requested by the Purchaser
for purposes of assessing the Application.

 

Article 5–
Conditions

 

		5.1	Mutual Conditions Precedent

 

The respective obligations of the parties hereto
to consummate the transactions contemplated hereby are subject to the satisfaction, on or prior to the Closing Time, of the Purchaser
and the Vendor having entered into the Note.

 

		5.2	Conditions to the Obligations of the Purchaser

 

Notwithstanding anything herein contained,
the obligation of the Purchaser to complete the transactions provided for herein will be subject to the fulfillment of the following
conditions at or prior to the Closing Time:

 

		(a)	The representations and warranties of the Vendor contained in this Agreement shall be true and
accurate on the date hereof and at the Closing Time with the same force and effect as though such representations and warranties
had been made as of the Closing Time (regardless of the date as of which the information in this Agreement is given).

 

		(b)	The Vendor shall have complied with all covenants and agreements herein agreed to be performed
or caused to be performed by them at or prior to the Closing Time.

 

    8

     

    

 

		(c)	The Vendor shall have
delivered to the Purchaser a certificate in a form satisfactory to the Purchaser confirming that the facts with respect to each
of the representations and warranties of the Vendor are as set out herein and remain true at the Closing Time and that the Vendor
has performed each of the covenants required to be performed by it hereunder.

 

		(d)	No order, decision or ruling of any court, tribunal or regulatory authority having jurisdiction
will have been made, and no action or proceeding will be pending or threatened which, in the opinion of counsel to the Purchaser,
is likely to result in an order, decision or ruling:

 

		(i)	to disallow, enjoin, prohibit or impose any limitations or conditions on the Transaction or the
transactions contemplated hereby; or

 

		(ii)	to impose any limitations or conditions which may have an adverse effect on the Application.

 

		(e)	All consents, approvals authorizations of any governmental or regulator authority or person whose
consent to the Transaction is required to be obtained in order to carry out the transactions contemplated hereby in compliance
with all laws and agreements binding upon the parties hereto will have been obtained.

 

The conditions contained in this Section 5.2
are inserted for the exclusive benefit of the Purchaser and may be waived in whole or in part by the Purchaser at any time. The
Vendor acknowledges that the waiver by the Purchaser of any condition or any part of any condition will constitute a waiver only
of such condition or such part of such condition, as the case may be, and will not constitute a waiver of any covenant, agreement,
representation or warranty made by the Vendor herein that corresponds or is related to such condition or such part of such condition,
as the case may be. If any of the conditions contained in this Section 5.2 are not fulfilled or complied with in all material respects
as herein provided, the Purchaser may, at or prior to the Closing Time at its option, rescind this Agreement by notice in writing
to the Vendor and in such event the Purchaser will be released from all obligations hereunder and, unless the condition or conditions
which have not been fulfilled are reasonably capable of being fulfilled or caused to be fulfilled by the Vendor, then the Vendor
will also be released from all obligations hereunder.

 

		5.3	Conditions to the Obligations of the Vendor

 

Notwithstanding anything herein contained,
the obligations of the Vendor to complete the transactions provided for herein will be subject to the fulfillment of the following
conditions at or prior to the Closing Time:

 

		(a)	The representations and warranties of the Purchaser contained in this Agreement or in any documents
delivered in order to carry out the transactions contemplated hereby will be true and accurate on the date hereof and at the Closing
Time with the same force and effect as though such representations and warranties had been made as of the Closing Time (regardless
of the date as of which the information in this Agreement is given).

 

		(b)	The Purchaser shall have complied with all covenants and agreements herein agreed to be performed
or caused to be performed by it at or prior to the Closing Time.

 

		(c)	The Purchaser shall have delivered to the Vendor a certificate confirming
that the facts with respect to each of the representations and warranties of the Purchaser are as set out herein at the Closing
Time and that the Purchaser has performed each of the covenants required to be performed by it hereunder.

 

    9

     

    

 

		(d)	The Purchaser obtaining the Valuation no later than December
31, 2020.

 

		(e)	There shall have been no material adverse change in the business of the Purchaser.

 

		(f)	No order, decision or ruling of any court, tribunal or regulatory authority having jurisdiction
will have been made, and no action or proceeding will be pending or threatened which, in the opinion of counsel to the Vendor,
is likely to result in an order, decision or ruling:

 

(i)       to
disallow, enjoin, prohibit or impose any limitations or conditions on the Transaction or the transactions contemplated hereby;
or

 

(ii)       to
impose any limitations or conditions which may have an adverse effect on the business of the Purchaser.

 

		(g)	All consents, approvals and authorizations of any governmental or regulatory authority or person
whose consent to the Transaction is required to be obtained in order to carry out the transactions contemplated hereby in compliance
with all laws and agreements binding upon the parties hereto will have been obtained.

 

The conditions contained in this Section 5.3
hereof are inserted for the exclusive benefit of the Vendor and may be waived in whole or in part by the Vendor at any time. The
Purchaser acknowledges that the waiver by the Vendor of any condition or any part of any condition will constitute a waiver only
of such condition or such part of such condition, as the case may be, and will not constitute a waiver of any covenant, agreement,
representation or warranty made by the Vendor herein that corresponds or is related to such condition or such part of such condition,
as the case may be. If any of the conditions contained in this Section 5.3 hereof are not fulfilled or complied with as herein
provided, the Vendor may, at or prior to the Closing Time at its option, rescind this Agreement by notice in writing to the Purchaser
and in such event the Vendor will be released from all obligations hereunder and, unless the condition or conditions which have
not been fulfilled are reasonably capable of being fulfilled or caused to be fulfilled by the Purchaser, then the Purchaser will
also be released from all obligations hereunder.

 

Article 6–CLOSING

 

		6.1	Vendor Deliveries

 

At the Closing Time, the Vendor shall deliver
to the Purchaser the following in form and substance satisfactory to the Purchaser:

 

		(a)	the certificate of the Vendor contemplated in Section 5.2;

 

		(b)	certified copy of the resolution of the directors and the shareholders of the Vendor authorizing
the execution and delivery of this Agreement and the performance by the Vendor of the terms of the Agreement; and

 

		(c)	all documentation and other evidence reasonably requested by the Purchaser in order to establish
the due authorization and consummation of the Transaction, including the taking of all corporate proceedings by the boards of directors
and shareholders of the Vendor required to effectively carry out the obligations of the Vendor pursuant to this Agreement.

 

    10

     

    

 

		6.2	Purchaser Deliveries

 

At the Closing Time, the Purchaser shall deliver
to the Vendor the following in form and substance satisfactory to the Vendor:

 

		(a)	the certificate of the Purchaser contemplated in Section 3.4;

 

		(b)	the Valuation;

 

		(c)	the Note, which shall be validly issued and executed by the Purchaser;

 

		(d)	a certified copy of the resolution of the directors of the Purchaser authorizing the execution
and delivery of this Agreement and the Note, and the performance by the Purchaser of the terms of the Agreement; and

 

		(e)	all documentation and other evidence reasonably requested by the Vendor in order to establish the
due authorization and consummation of the Transaction, including the taking of all corporate proceedings by the boards of directors
and shareholders of the Purchaser required to effectively carry out the obligations of the Purchaser pursuant to this Agreement.

 

		6.3	Post-Closing Obligation

 

Forthwith following the date (“Completion
Date”) that the Purchaser pays the entire Note and all Accrued Interest to the Vendor, the Vendor shall deliver an executed
bill of sale to the Purchaser dated as of the Completion Date relating to the Application purchase contemplated by this Agreement
pursuant to which the Vendor sells, assigns and transfer to the Purchaser a 100% undivided interest in the Application, free and
clear of all Encumbrances whatsoever.

 

		6.4	Place of Closing

 

The Closing shall take place at the Closing
Time at the offices of the Purchaser or at such other place as the Purchaser and the Vendor may agree upon in writing.

 

Article 7–
INDEMNIFICATION

 

		7.1	Purchaser Indemnity

 

The
Purchaser will indemnify, defend, and hold harmless the Vendor from, against, for, and in respect of any and all Losses asserted
against, relating to, imposed upon, or incurred by the Vendor by reason of, resulting from, based upon or arising out of (i) any
misrepresentation, misstatement or breach of warranty of the Purchaser contained in or made pursuant to this Agreement or any certificate
or other instrument delivered pursuant to this Agreement; or (ii) the breach or partial breach by the Purchaser of any covenant
or agreement of the Purchaser made in or pursuant to this Agreement or any certificate or other instrument delivered pursuant to
this Agreement.

 

		7.2	Vendor Indemnity

 

The Vendor will indemnify, defend, and hold
harmless the Purchaser from, against, for, and in respect of any and all Losses asserted against, relating to, imposed upon, or
incurred by the Purchaser by reason of, resulting from, based upon or arising out of (i) any misrepresentation, misstatement or
breach of warranty of Vendor contained in or made pursuant to this Agreement or any certificate or other instrument delivered pursuant
to this Agreement; or (ii) the breach or partial breach by the Vendor of any covenant or agreement of the Vendor made in or pursuant
to this Agreement or any certificate or other instrument delivered pursuant to this Agreement.

 

    11

     

    

 

Article 8-
ARBITRATION

 

		8.1	Reasonable Commercial Efforts to Settle Disputes

 

If any controversy, dispute, claim, question
or difference (a “Dispute”) arises with respect to this Agreement or its performance, enforcement, breach, termination
or validity, the Parties to the Dispute will use all commercially reasonable efforts to settle the Dispute. To this end, they will
consult and negotiate with each other in good faith and understanding of their mutual interests to reach a just and equitable solution
satisfactory to all such Parties.

 

		8.2	Arbitration

 

Except as is expressly provided in this Agreement,
if the Parties do not reach a solution pursuant to Section 8.1 within a period of 15 Business Days following the first notice
of the Dispute by any Party to the other party(ies) to the Dispute, then upon written notice by any Party to the other party(ies)
to the Dispute, the Dispute will be submitted to binding arbitration in accordance with the provisions of the American Arbitration
Association in accordance with its then-current rules. The arbitration demand and counterclaim(s) must contain a clear and concise
statement of the Dispute. The respondent’s answer and any counterclaims must be filed within 20 calendar days of service
of the demand. In connection with any arbitration proceeding, each party must submit any dispute or claim which would constitute
a compulsory counterclaim (as defined by Rule 13 of the Federal Rules of Civil Procedure) in the arbitration. Any such claim which
is not submitted or filed as described hereinabove will be forever barred and must be considered waived. Judgment on the award
rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.

 

Article 9–
GENERAL

 

		9.1	Confidentiality

 

The Purchaser covenants and agrees that, except
as otherwise authorized by the Vendor and until the Closing, neither the Purchaser nor its representatives, agents or employees
will disclose to third parties, directly or indirectly, any confidential information or confidential data relating to the Vendor
or the Business discovered or received by the Purchaser or its representatives, agents or employees as a result of the Vendor making
available to the Purchaser and its representatives, agents or employees the information requested by them in connection with the
Transaction.

 

		9.2	Notices

 

(1)       Any
notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person,
transmitted by facsimile or similar means of recorded electronic communication or sent by registered mail, charges prepaid, addressed
as follows:

 

		(a)	if to the Vendor:

 

Limitless Projects Inc. 

420 North Nellis A3-146, Las Vegas, Nevada, 89110 

Email: info@limitlessprojectsinc.com

 

    12

     

    

 

		(b)	if to the Purchaser:

 

WarpSpeed Taxi Inc. 

9436 W. Lake Mead Blvd, Las Vegas, NV 89134

Email: info@cyberappsworld.com

 

(2)       Any
such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted
(or, if such day is not a Business Day, on the next following Business Day) or, if mailed, on the third Business Day following
the date of mailing; provided, however, that if at the time of mailing or within three Business Days thereafter there is or occurs
a labor dispute or other event that might reasonably be expected to disrupt the delivery of documents by mail, any notice or other
communication hereunder shall be delivered or transmitted by means of recorded electronic communication as described.

 

(3)       Any
Party may at any time change its address for service from time to time by giving notice to the other Parties in accordance with
this Section 9.3.

 

		9.3	Public Announcements and Disclosure

 

The Parties shall consult with each other before
issuing any press release or making any other public announcement with respect to this Agreement or the Transaction and, except
as required by any applicable Law or stock exchange having jurisdiction, no Party shall issue any such press release or make any
such public announcement without the prior written consent of the others, which consent shall not be unreasonably withheld or delayed.
Prior to any such press release or public announcement, none of the Parties shall disclose this Agreement or any aspect of the
Transaction except to its board of directors, its senior management, its legal, accounting, financial or other professional advisors,
any financial institution contacted by it with respect to any financing required in connection with the Transaction and counsel
to such institution, or as may be required by any applicable Law or stock exchange having jurisdiction.

 

		9.4	Assignment

 

The rights of the Purchaser hereunder are not
assignable without the written consent of the Vendor. The rights of the Vendor hereunder are not assignable without the written
consent of the Purchaser.

 

		9.5	Commercially Reasonable Efforts

 

The Parties acknowledge and agree that, for
all purposes of this Agreement, an obligation on the part of any Party to use its “commercially reasonable efforts” to
obtain any waiver, Consent or other document shall not require such Party to make any payment to any person for the purpose of
procuring the same, other than payments for amounts due and payable to such person, payments for incidental expenses incurred by
such person and payments required by any applicable law or regulation.

 

		9.6	Expenses

 

Unless otherwise provided, each of the Vendor
and the Purchaser shall be responsible for the expenses (including fees and expenses of legal advisers, accountants and other professional
advisers) incurred by them, respectively, in connection with the negotiation and settlement of this Agreement and the completion
of the Transaction. In the event of termination of this Agreement, the obligation of each Party to pay its own expenses will be
subject to any rights of such Party arising from a breach of this Agreement by another Party. The Purchaser shall be exclusively
responsible for the cost of the Valuation.

 

		9.7	Further Assurances

 

Each of the Parties shall promptly do, make,
execute, deliver, or cause to be done, made, executed or delivered, all such further acts, documents and things as the other Parties
may reasonably require from time to time after Closing at the expense of the requesting Party for the purpose of giving effect
to this Agreement and shall use reasonable efforts and take all such steps as may be reasonably within its power to implement to
their full extent the provisions of this Agreement.

 

    13

     

    

 

		9.8	Entire Agreement

 

This Agreement constitutes the entire agreement
between the Parties with respect to the subject matter and supersedes all prior agreements, understandings, negotiations and discussions,
whether written or oral. There are no conditions, covenants, agreements, representations, warranties or other provisions, express
or implied, collateral, statutory or otherwise, relating to the subject matter except provided in this Agreement. No reliance is
placed by any Party on any warranty, representation, opinion, advice or assertion of fact made by any Party or its directors, officers,
employees or agents, to any other Party or its directors, officers, employees or agents, except to the extent that it has been
reduced to writing and included in this Agreement.

 

		9.9	Waiver, Amendment

 

Except as expressly provided in this Agreement,
no amendment or waiver of this Agreement shall be binding unless executed in writing by the Party to be bound. No waiver of any
provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any provision of this Agreement
constitute a continuing waiver unless otherwise expressly provided.

 

		9.10	Rights Cumulative

 

The rights and remedies of the Parties are
cumulative and not alternative.

 

		9.11	Counterparts

 

This Agreement may be executed in any number
of counterparts, and/or by facsimile or e-mail transmission of Adobe Acrobat files, each of which shall constitute an original
and all of which, taken together, shall constitute one and the same instrument. Any Party executing this Agreement by fax or Adobe
Acrobat file shall, immediately following a request by any other Party, provide an originally executed counterpart of this Agreement
provided, however, that any failure to so provide shall not constitute a breach of this Agreement.

 

IN WITNESS WHEREOF this Agreement has been
executed by the Parties.

 

WARPSPEED TAXI INC.

 

Per:/s/ Kateryna Malenko

 

Authorized Signatory

 

 

LIMITLESS PROJECTS INC.

 

Per: /s/ Salim Rana

 

Authorized Signatory

 

    14ex101-cindigemploymentag

   EXHIBIT 10.1  SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT  This Second Amended and Restated Employment Agreement (“Agreement”) is made  between Phreesia, Inc., a Delaware corporation (the “Company”), and Chaim Indig (the  “Executive”) and is effective as of February 1, 2021.  WHEREAS, the Company and the Executive previously entered into that certain  Amended and Restated Employment Agreement dated as of July 2019 (“Prior Agreement”);  WHEREAS, the Company desires to continue to employ the Executive and the Executive  desires to continue to be employed by the Company on the new terms and conditions contained  herein and, accordingly, desire to amend and restate the Prior Agreement.  NOW, THEREFORE, in consideration of the mutual covenants and agreements herein  contained and other good and valuable consideration, the receipt and sufficiency of which is  hereby acknowledged, the parties agree as follows:  1. Employment.  (a) Term.   The Company shall continue to employ the Executive and the  Executive shall continue to be employed by the Company pursuant to this Agreement  commencing as of the Effective Date and continuing until such employment is terminated in  accordance with the provisions hereof (the “Term”).  The Executive’s employment with the  Company will continue to be “at will,” meaning that the Executive’s employment may be  terminated by the Company or the Executive at any time and for any reason subject to the terms  of this Agreement.  (b) Position and Duties.  During the Term, the Executive shall serve as the  Chief Executive Officer (CEO) of the Company and shall have such powers and duties as may  from time to time be prescribed by the Board of Directors (the “Board”).  The Executive shall  devote the Executive’s full working time and efforts to the business and affairs of the Company.   Notwithstanding the foregoing, the Executive may serve on other boards of directors, with the  approval of the Board of Directors of the Company (the “Board”), or engage in religious,  charitable or other community activities as long as such services and activities are disclosed to  the Board and do not interfere with the Executive’s performance of the Executive’s duties to the  Company.     2. Compensation and Related Matters.  (a) Base Salary.  Effective as of February 1, 2021, the Executive’s initial base  salary shall be paid at the rate of $515,000 per year.  The Executive’s base salary shall be  reviewed annually by the Board or the Compensation Committee of the Board (the  “Compensation Committee”).  The base salary in effect at any given time is referred to herein as  “Base Salary.”  The Base Salary shall be payable in a manner that is consistent with the  Company’s usual payroll practices for executive officers.  

 

   2    (b) Incentive Compensation.  During the Term, the Executive shall be eligible  to receive cash incentive compensation as determined by the Board or the Compensation  Committee from time to time.  The Executive’s initial target annual incentive compensation shall  be $515,000 which is equivalent to 100% of the Executive’s Base Salary (the “Target Bonus”).   The actual amount of the Executive’s annual incentive compensation, if any, shall be determined  in the sole discretion of the Board or the Compensation Committee, subject to the terms of any  applicable incentive compensation plan that may be in effect from time to time.  Except as  otherwise provided herein, to earn incentive compensation, the Executive must be employed by  the Company on the day such incentive compensation is paid.    (c) Expenses.  The Executive shall be entitled to receive prompt  reimbursement for all reasonable expenses incurred by the Executive during the Term in  performing services hereunder, in accordance with the policies and procedures then in effect and  established by the Company for its executive officers.  (d) Other Benefits.  During the Term, the Executive shall be eligible to  participate in or receive benefits under the Company’s employee benefit plans in effect from  time to time, subject to the terms of such plans.  (e) Paid Time Off.  During the Term, the Executive shall be entitled to take  paid time off in accordance with the Company’s applicable paid time off policy for executives,  as may be in effect from time to time.  The Executive shall also be entitled to all paid holidays  given by the Company to its executive officers.  (f) Equity.  The equity awards held by the Executive shall continue to be  governed by the terms and conditions of the Company’s applicable equity incentive plan(s) and  the applicable award agreement(s) governing the terms of such equity awards held by the  Executive (collectively, the “Equity Documents”); provided, however, and notwithstanding  anything to the contrary in the Equity Documents, in the event of a termination by the Company  without Cause or by the Executive for Good Reason (as such terms are defined below), Section  5(c) or Section 6(a)(ii) of this Agreement, as applicable, shall apply.  In the event of a Change in  Control, notwithstanding anything to the contrary in any applicable option agreement or other  stock-based award agreement, (i) fifty-percent (50%) of any then-unvested time-based stock  options and other stock-based awards subject to time-based vesting held by the Executive (the  “Time-Based Equity Awards”) shall immediately accelerate and become fully exercisable or  nonforfeitable as of the date of such Change in Control (with such acceleration to apply to any  awards scheduled to vest earliest in time) and (ii) subject to Section 6(a)(ii) of this Agreement,  the remaining Time-Based Equity Awards shall accelerate and become fully exercisable or  nonforfeitable as of the date of the first anniversary of the Change in Control, subject to the  Executive’s continued service through such date.  3. Termination.  During the Term, the Executive’s employment hereunder may be  terminated without any breach of this Agreement under the following circumstances:  (a) Death.  The Executive’s employment hereunder shall terminate upon  death.  

 

   3    (b) Disability.  The Company may terminate the Executive’s employment if  the Executive is disabled and unable to perform the essential functions of the Executive’s then  existing position or positions under this Agreement with or without reasonable accommodation  for a period of 180 days (which need not be consecutive) in any 12-month period.  If any  question shall arise as to whether during any period the Executive is disabled so as to be unable  to perform the essential functions of the Executive’s then existing position or positions with or  without reasonable accommodation, the Executive may, and at the request of the Company shall,  submit to the Company a certification in reasonable detail by a physician selected by the  Company to whom the Executive or the Executive’s guardian has no reasonable objection as to  whether the Executive is so disabled or how long such disability is expected to continue, and  such certification shall for the purposes of this Agreement be conclusive of the issue.  The  Executive shall cooperate with any reasonable request of the physician in connection with such  certification.  If such question shall arise and the Executive shall fail to submit such certification,  the Company’s determination of such issue shall be binding on the Executive.  Nothing in this  Section 3(b) shall be construed to waive the Executive’s rights, if any, under existing law  including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et  seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq.    (c) Termination by the Company for Cause.  The Company may terminate the  Executive’s employment hereunder for Cause.  For purposes of this Agreement, “Cause” shall  mean any of the following:    (i) conduct by the Executive constituting a material act of misconduct  in connection with the performance of the Executive’s duties, including, without limitation, (A)  willful failure or refusal to perform material responsibilities that have been requested by the  Board; (B) dishonesty to the Board with respect to any material matter; or (C) misappropriation  of funds or property of the Company or any of its subsidiaries or affiliates other than the  occasional, customary and de minimis use of Company property for personal purposes;   (ii) the commission by the Executive of acts satisfying the elements of  (A) any felony or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud;   (iii) any misconduct by the Executive, regardless of whether or not in  the course of the Executive’s employment, that would reasonably be expected to result in  material injury or reputational harm to the Company or any of its subsidiaries or affiliates if the  Executive were to continue to be employed in the same position;   (iv) continued unsatisfactory performance or non-performance by the  Executive of the Executive’s duties hereunder (other than by reason of the Executive’s physical  or mental illness, incapacity or disability) which has continued for more than 30 days following  written notice of such unsatisfactory performance or non-performance from the Board;   (v) a breach by the Executive of any of the provisions contained in  Section 8 of this Agreement or the Restrictive Covenants Agreement (as defined below);   (vi) a material violation by the Executive of any of the Company’s  written employment policies; or   

 

   4    (vii) the Executive’s failure to cooperate with a bona fide internal  investigation or an investigation by regulatory or law enforcement authorities, after being  instructed by the Company to cooperate, or the willful destruction or failure to preserve  documents or other materials known to be relevant to such investigation or the inducement of  others to fail to cooperate or to produce documents or other materials in connection with such  investigation.  (d) Termination by the Company without Cause.  The Company may  terminate the Executive’s employment hereunder at any time without Cause.  Any termination by  the Company of the Executive’s employment under this Agreement which does not constitute a  termination for Cause under Section 3(c) and does not result from the death or disability of the  Executive under Section 3(a) or (b) shall be deemed a termination without Cause.  (e) Termination by the Executive without Good Reason.  The Executive may  terminate employment hereunder at any time without Good Reason (as defined below).  (f) Termination by the Executive with Good Reason.  The Executive may  terminate employment hereunder with Good Reason.   For purposes of this Agreement, “Good  Reason” shall mean that the Executive has completed all steps of the Good Reason Process  (hereinafter defined) following the occurrence of any of the following events without the  Executive’s consent (each, a “Good Reason Condition”):  (i) a material reduction in cash  compensation (other than a reduction in the amount of variable compensation actually earned  due to the failure to meet performance targets); or (ii) solely to the extent such termination  occurs during the Change in Control Period, (A) a material diminution in the Executive’s  responsibilities, authority or duties; (B) the Executive shall no longer report directly to the  Board; (C) a material change in the geographic location at which the Executive provides services  to the Company, such that there is an increase of at least thirty (30) miles of driving distance to  such location from the Executive’s principal residence as of such change; or (D) a material  breach of this Agreement.  The “Good Reason Process” consists of the following steps: (a) the  Executive reasonably determines in good faith that a Good Reason Condition has occurred; (b)  the Executive notifies the Company in writing of the first occurrence of the Good Reason  Condition within 60 days of the first occurrence of such condition; (d) the Executive cooperates  in good faith with the Company’s efforts, for a period of not less than 30 days following such  notice (the “Cure Period”), to remedy the Good Reason Condition; (e) notwithstanding such  efforts, the Good Reason Condition continues to exist; and the Executive terminates employment  within 60 days after the end of the Cure Period. If the Company cures the Good Reason  condition during the Cure Period, Good Reason shall be deemed not to have occurred.    4. Notice and Date of Termination.  (a) Notice of Termination.  Except for termination as specified in Section  3(a), any termination of the Executive’s employment by the Company or any such termination  by the Executive shall be communicated by written Notice of Termination to the other party  hereto.  For purposes of this Agreement, a “Notice of Termination” shall mean a notice which  shall indicate the specific termination provision in this Agreement relied upon.  

 

   5    (b) Date of Termination.  “Date of Termination” shall mean:  (i) if the  Executive’s employment is terminated by death, the date of death; (ii) if the Executive’s  employment is terminated on account of disability under Section 3(b) or by the Company for  Cause under Section 3(c), the date on which Notice of Termination is given; (iii) if the  Executive’s employment is terminated by the Company under Section 3(d), the date on which a  Notice of Termination is given or the date otherwise specified by the Company in the Notice of  Termination; (iv) if the Executive’s employment is terminated by the Executive under Section  3(e), 30 days after the date on which a Notice of Termination is given, and (v) if the Executive’s  employment is terminated by the Executive under Section 3(f), the date on which a Notice of  Termination is given after the end of the Cure Period.  Notwithstanding the foregoing, in the  event that the Executive gives a Notice of Termination to the Company, the Company may  unilaterally accelerate the Date of Termination and such acceleration shall not result in a  termination by the Company for purposes of this Agreement.   (c) Accrued Obligations.   If the Executive’s employment with the Company  is terminated for any reason, the Company shall pay or provide to the Executive (or to the  Executive’s authorized representative or estate) (i) any Base Salary earned through the Date of  Termination; (ii) unpaid expense reimbursements (subject to, and in accordance with, Section  2(c) of this Agreement); and (iii) any vested benefits the Executive may have under any  employee benefit plan of the Company through the Date of Termination, which vested benefits  shall be paid and/or provided in accordance with the terms of such employee benefit plans  (collectively, the “Accrued Obligations”).  5. Severance Pay and Benefits Upon Termination by the Company without Cause  Outside the Change in Control Period.  During the Term, if the Executive’s employment is  terminated by the Company without Cause as provided in Section 3(d), or the Executive  terminates employment for Good Reason (due to the Good Reason Condition described in clause  (i) of the definition thereof), in each case outside of the Change in Control Period, then the  Company shall pay the Executive the Accrued Obligations.  In addition, subject to (i) the  Executive signing a separation agreement and release in a form and manner satisfactory to the  Company, which shall include, without limitation, a general release of claims against the  Company and all related persons and entities, and a reaffirmation of all of the Executive’s  Continuing Obligations (as defined below), and shall provide that if the Executive breaches any  of the Continuing Obligations, all payments of the Severance Amount shall immediately cease  (the “Separation Agreement and Release”), and (ii) the Separation Agreement and Release  becoming irrevocable, all within 60 days after the Date of Termination (or such shorter period as  set forth in the Separation Agreement and Release), which shall include a seven (7) business day  revocation period:  (a) the Company shall pay the Executive an amount equal to eighteen (18)  months of the Executive’s Base Salary (the “Severance Amount”); and  (b) the Company shall pay the Executive an amount equal to a prorated bonus  for the fiscal year in which the Date of Termination occurs, which prorated amount shall be  calculated based on actual performance during such fiscal year and then prorating such bonus  based on when in the fiscal year the Date of Termination occurs (the “Prorated Bonus”);  

 

   6    (c) notwithstanding anything to the contrary in any applicable option  agreement or other stock-based award agreement, all Time-Based Equity Awards, to the extent  such Time-Based Equity Awards otherwise would have become fully exercisable or  nonforfeitable during the eighteen (18) month period following the Date of Termination, shall  immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the  Date of Termination or (ii) the effective date of the Separation Agreement and Release (the  “Accelerated Vesting Date”); provided that any termination or forfeiture of the unvested portion  of such Time-Based Equity Awards that would otherwise occur on the Date of Termination in  the absence of this Agreement will be delayed until the effective date of the Separation  Agreement and Release and will only occur if the vesting pursuant to this subsection does not  occur due to the absence of the Separation Agreement and Release becoming fully effective  within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of  the Time-Based Equity Awards shall occur during the period between the Executive’s Date of  Termination and the Accelerated Vesting Date;  (d) subject to the Executive’s copayment of premium amounts at the  applicable active employees’ rate and the Executive’s proper election to receive benefits under  the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the  Company shall pay to the group health plan provider, the COBRA provider or the Executive a  monthly payment equal to the monthly employer contribution that the Company would have  made to provide health insurance to the Executive if the Executive had remained employed by  the Company until the earliest of (A) the eighteen (18) month anniversary of the Date of  Termination; (B) the Executive’s eligibility for group medical plan benefits under any other  employer’s group medical plan; or (C) the cessation of the Executive’s continuation rights under  COBRA; provided, however, if the Company determines that it cannot pay such amounts to the  group health plan provider or the COBRA provider (if applicable) without potentially violating  applicable law (including, without limitation, Section 2716 of the Public Health Service Act),  then the Company shall convert such payments to payroll payments directly to the Executive for  the time period specified above.  Such payments shall be subject to tax-related deductions and  withholdings and paid on the Company’s regular payroll dates.  For the avoidance of doubt, the  taxable payments described above may be used for any purpose, including, but not limited to,  continuation coverage under COBRA.  The amounts payable under Section 5, to the extent taxable, shall be paid out in substantially  equal installments in accordance with the Company’s payroll practice over eighteen (18) months  commencing within 60 days after the Date of Termination; provided, however, that if the 60-day  period begins in one calendar year and ends in a second calendar year, the Severance Amount, to  the extent it qualifies as “non-qualified deferred compensation” within the meaning of Section  409A of the Internal Revenue Code of 1986, as amended (the “Code”), shall begin to be paid in  the second calendar year by the last day of such 60-day period; provided, further, that the initial  payment shall include a catch-up payment to cover amounts retroactive to the day immediately  following the Date of Termination.  The Prorated Bonus shall be paid at the time such bonuses  are normally paid to employees of the Company for such fiscal year (but in no event later than  March 15 of the year following the year in which the Date of Termination occurs).  Each  payment pursuant to this Agreement is intended to constitute a separate payment for purposes of  Treasury Regulation Section 1.409A-2(b)(2).  

 

   7    6. Severance Pay and Benefits Upon Termination by the Company without Cause or  by the Executive for Good Reason within the Change in Control Period.  The provisions of this  Section 6 shall apply in lieu of, and expressly supersede, the provisions of Section 5 regarding  severance pay and benefits upon a termination by the Company without Cause or by the  Executive for Good Reason if such termination of employment occurs within twenty-four (24)  months after the occurrence of the first event constituting a Change in Control (such period, the  “Change in Control Period”). These provisions shall terminate and be of no further force or  effect after the Change in Control Period.  (a) Change in Control Period.  During the Term, if during the Change in  Control Period the Executive’s employment is terminated by the Company without Cause as  provided in Section 3(d) or the Executive terminates employment for Good Reason, then, subject  to the signing of the Separation Agreement and Release by the Executive and the Separation  Agreement and Release becoming fully effective, all within the time frame set forth in the  Separation Agreement and Release but in no event more than 60 days after the Date of  Termination:  (i) the Company shall pay the Executive a lump sum in cash in an  amount equal to the sum of (i) two (2) times the sum of (A) the Executive’s then current  Base Salary (or the Executive’s Base Salary in effect immediately prior to the Change in  Control, if higher) plus (B) the Executive’s Target Bonus for the then-current year and  (ii) a prorated bonus for the fiscal year in which the Date of Termination occurs, which  prorated amount shall be calculated by assuming such bonus is awarded at target and then  prorating such bonus based on when in the fiscal year the Date of Termination occurs  (collectively, the “Change in Control Payment”); and  (ii) notwithstanding anything to the contrary in any applicable option  agreement or other stock-based award agreement, to the extent not previously accelerated  pursuant to Section 2(f), all Time-Based Equity Awards shall immediately accelerate and  become fully exercisable or nonforfeitable as of the later of (i) the Date of Termination or  (ii) the Accelerated Vesting Date; provided that any termination or forfeiture of the  unvested portion of such Time-Based Equity Awards that would otherwise occur on the  Date of Termination in the absence of this Agreement will be delayed until the Effective  Date of the Separation Agreement and Release and will only occur if the vesting pursuant  to this subsection does not occur due to the absence of the Separation Agreement and  Release becoming fully effective within the time period set forth therein.   Notwithstanding the foregoing, no additional vesting of the Time-Based Equity Awards  shall occur during the period between the Executive’s Date of Termination and the  Accelerated Vesting Date; and  (iii) subject to the Executive’s copayment of premium amounts at the  applicable active employees’ rate and the Executive’s proper election to receive benefits  under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended  (“COBRA”), the Company shall pay to the group health plan provider, the COBRA  provider or the Executive a monthly payment equal to the monthly employer contribution  that the Company would have made to provide health insurance to the Executive if the  Executive had remained employed by the Company until the earliest of (A) the eighteen  

 

   8    (18) month anniversary of the Date of Termination; (B) the Executive’s eligibility for  group medical plan benefits under any other employer’s group medical plan; or (C) the  cessation of the Executive’s continuation rights under COBRA; provided, however, if the  Company determines that it cannot pay such amounts to the group health plan provider or  the COBRA provider (if applicable) without potentially violating applicable law  (including, without limitation, Section 2716 of the Public Health Service Act), then the  Company shall convert such payments to payroll payments directly to the Executive for  the time period specified above.  Such payments shall be subject to tax-related deductions  and withholdings and paid on the Company’s regular payroll dates.  For the avoidance of  doubt, the taxable payments described above may be used for any purpose, including, but  not limited to, continuation coverage under COBRA.  The amounts payable under this Section 6(a), to the extent taxable, shall be paid or commence to  be paid within 60 days after the Date of Termination; provided, however, that if the 60-day  period begins in one calendar year and ends in a second calendar year, such payments to the  extent they qualify as “non-qualified deferred compensation” within the meaning of Section  409A of the Code, shall be paid or commence to be paid in the second calendar year by the last  day of such 60-day period.  (b) Additional Limitation.  (i) Anything in this Agreement to the contrary notwithstanding, in the  event that the amount of any compensation, payment or distribution by the Company to  or for the benefit of the Executive, whether paid or payable or distributed or distributable  pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent  with Section 280G of the Code, and the applicable regulations thereunder (the  “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of  the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the  sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the  Executive becomes subject to the excise tax imposed by Section 4999 of the Code;  provided that such reduction shall only occur if it would result in the Executive receiving  a higher After Tax Amount (as defined below) than the Executive would receive if the  Aggregate Payments were not subject to such reduction.  In such event, the Aggregate  Payments shall be reduced in the following order, in each case, in reverse chronological  order beginning with the Aggregate Payments that are to be paid the furthest in time from  consummation of the transaction that is subject to Section 280G of the Code:  (1) cash  payments not subject to Section 409A of the Code; (2) cash payments subject to Section  409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of  benefits; provided that in the case of all the foregoing Aggregate Payments all amounts or  payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or  (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg.  §1.280G-1, Q&A-24(b) or (c).  (ii) For purposes of this Section 6(b), the “After Tax Amount” means  the amount of the Aggregate Payments less all federal, state, and local income, excise and  employment taxes imposed on the Executive as a result of the Executive’s receipt of the  Aggregate Payments.  For purposes of determining the After Tax Amount, the Executive  

 

   9    shall be deemed to pay federal income taxes at the highest marginal rate of federal  income taxation applicable to individuals for the calendar year in which the determination  is to be made, and state and local income taxes at the highest marginal rates of individual  taxation in each applicable state and locality, net of the maximum reduction in federal  income taxes which could be obtained from deduction of such state and local taxes.   (iii) The determination as to whether a reduction in the Aggregate  Payments shall be made pursuant to Section 6(b)(i) shall be made by a nationally  recognized accounting firm selected by the Company (the “Accounting Firm”), which  shall provide detailed supporting calculations both to the Company and the Executive  within 15 business days of the Date of Termination, if applicable, or at such earlier time  as is reasonably requested by the Company or the Executive.  Any determination by the  Accounting Firm shall be binding upon the Company and the Executive.  (c) Definitions.  For purposes of this Section 6, the following terms shall have  the following meanings:  “Change in Control” shall mean any of the following:  (i) any “person,” as such term is used in Sections 13(d) and 14(d) of  the Securities Exchange Act of 1934, as amended (the “Act”) (other than the Company,  any of its subsidiaries, or any trustee, fiduciary or other person or entity holding securities  under any employee benefit plan or trust of the Company or any of its subsidiaries),  together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2  under the Act) of such person, shall become the “beneficial owner” (as such term is  defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company  representing 50 percent or more of the combined voting power of the Company’s then  outstanding securities having the right to vote in an election of the Board (“Voting  Securities”) (in such case other than as a result of an acquisition of securities directly  from the Company); or  (ii) the date a majority of the members of the Board is replaced during  any 12-month period by directors whose appointment or election is not endorsed by a  majority of the members of the Board before the date of the appointment or election; or  (iii) the consummation of (A) any consolidation or merger of the  Company where the stockholders of the Company, immediately prior to the consolidation  or merger, would not, immediately after the consolidation or merger, beneficially own (as  such term is defined in Rule 13d-3 under the Act), directly or indirectly, shares  representing in the aggregate more than 50 percent of the voting shares of the Company  issuing cash or securities in the consolidation or merger (or of its ultimate parent  corporation, if any), or (B) any sale or other transfer (in one transaction or a series of  transactions contemplated or arranged by any party as a single plan) of all or substantially  all of the assets of the Company.   Notwithstanding the foregoing, a “Change in Control” shall not be deemed to have  occurred for purposes of the foregoing clause (i) solely as the result of an acquisition of  

 

   10    securities by the Company which, by reducing the number of shares of Voting Securities  outstanding, increases the proportionate number of Voting Securities beneficially owned by any  person to 50 percent or more of the combined voting power of all of the then outstanding Voting  Securities; provided, however, that if any person referred to in this sentence shall thereafter  become the beneficial owner of any additional shares of Voting Securities (other than pursuant to  a stock split, stock dividend, or similar transaction or as a result of an acquisition of securities  directly from the Company) and immediately thereafter beneficially owns 50 percent or more of  the combined voting power of all of the then outstanding Voting Securities, then a “Change in  Control” shall be deemed to have occurred for purposes of the foregoing clause (i).  7. Section 409A.  (a) Anything in this Agreement to the contrary notwithstanding, if at the time  of the Executive’s separation from service within the meaning of Section 409A of the Code, the  Company determines that the Executive is a “specified employee” within the meaning of Section  409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive  becomes entitled to under this Agreement or otherwise on account of the Executive’s separation  from service would be considered deferred compensation otherwise subject to the 20 percent  additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of  Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall  not be provided until the date that is the earlier of (A) six months and one day after the  Executive’s separation from service, or (B) the Executive’s death.  If any such delayed cash  payment is otherwise payable on an installment basis, the first payment shall include a catch-up  payment covering amounts that would otherwise have been paid during the six-month period but  for the application of this provision, and the balance of the installments shall be payable in  accordance with their original schedule.   (b) All in-kind benefits provided and expenses eligible for reimbursement  under this Agreement shall be provided by the Company or incurred by the Executive during the  time periods set forth in this Agreement.  All reimbursements shall be paid as soon as  administratively practicable, but in no event shall any reimbursement be paid after the last day of  the taxable year following the taxable year in which the expense was incurred.  The amount of  in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect  the in-kind benefits to be provided or the expenses eligible for reimbursement in any other  taxable year (except for any lifetime or other aggregate limitation applicable to medical  expenses).  Such right to reimbursement or in-kind benefits is not subject to liquidation or  exchange for another benefit.  (c) To the extent that any payment or benefit described in this Agreement  constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the  extent that such payment or benefit is payable upon the Executive’s termination of employment,  then such payments or benefits shall be payable only upon the Executive’s “separation from  service.”  The determination of whether and when a separation from service has occurred shall  be made in accordance with the presumptions set forth in Treasury Regulation Section  1.409A-1(h).  

 

   11    (d) The parties intend that this Agreement will be administered in accordance  with Section 409A of the Code.  To the extent that any provision of this Agreement is ambiguous  as to its compliance with Section 409A of the Code, the provision shall be read in such a manner  so that all payments hereunder comply with Section 409A of the Code.  Each payment pursuant  to this Agreement or the Restrictive Covenants Agreement is intended to constitute a separate  payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).  The parties agree that this  Agreement may be amended, as reasonably requested by either party, and as may be necessary to  fully comply with Section 409A of the Code and all related rules and regulations in order to  preserve the payments and benefits provided hereunder without additional cost to either party.  (e) The Company makes no representation or warranty and shall have no  liability to the Executive or any other person if any provisions of this Agreement are determined  to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an  exemption from, or the conditions of, such Section.  8. Continuing Obligations.   (a) Restrictive Covenants Agreement.  The terms of the Employee  Confidentiality and Assignment Agreement, dated January 2008 (the “Restrictive Covenants  Agreement”), between the Company and the Executive, attached hereto as Exhibit A, continue to  be in full force and effect. For purposes of this Agreement, the obligations in this Section 8 and  those that arise in the Restrictive Covenants Agreement and any other agreement relating to  confidentiality, assignment of inventions, or other restrictive covenants shall collectively be  referred to as the “Continuing Obligations.”    (b) Third-Party Agreements and Rights.  The Executive hereby confirms that  the Executive is not bound by the terms of any agreement with any previous employer or other  party which restricts in any way the Executive’s use or disclosure of information, other than  confidentiality restrictions (if any), or the Executive’s engagement in any business.  The  Executive represents to the Company that the Executive’s execution of this Agreement, the  Executive’s employment with the Company and the performance of the Executive’s proposed  duties for the Company will not violate any obligations the Executive may have to any such  previous employer or other party.  In the Executive’s work for the Company, the Executive will  not disclose or make use of any information in violation of any agreements with or rights of any  such previous employer or other party, and the Executive will not bring to the premises of the  Company any copies or other tangible embodiments of non-public information belonging to or  obtained from any such previous employment or other party.  (c) Litigation and Regulatory Cooperation.  During and after the Executive’s  employment, the Executive shall cooperate fully with the Company in (i) the defense or  prosecution of any claims or actions now in existence or which may be brought in the future  against or on behalf of the Company which relate to events or occurrences that transpired while  the Executive was employed by the Company, and (ii) the investigation, whether internal or  external, of any matters about which the Company believes the Executive may have knowledge  or information.  The Executive’s full cooperation in connection with such claims, actions or  investigations shall include, but not be limited to, being available to meet with counsel to answer  questions or to prepare for discovery or trial and to act as a witness on behalf of the Company at  

 

   12    mutually convenient times.  During and after the Executive’s employment, the Executive also  shall cooperate fully with the Company in connection with any investigation or review of any  federal, state or local regulatory authority as any such investigation or review relates to events or  occurrences that transpired while the Executive was employed by the Company.  The Company  shall reimburse the Executive for any reasonable out-of-pocket expenses incurred in connection  with the Executive’s performance of obligations pursuant to this Section 8(c).  (d) Relief.  The Executive agrees that it would be difficult to measure any  damages caused to the Company which might result from any breach by the Executive of the  Continuing Obligations, and that in any event money damages would be an inadequate remedy  for any such breach.  Accordingly, the Executive agrees that if the Executive breaches, or  proposes to breach, any portion of the Continuing Obligations, the Company shall be entitled, in  addition to all other remedies that it may have, to an injunction or other appropriate equitable  relief to restrain any such breach without the posting of a bond and without showing or proving  any actual damage to the Company.  (e) Protected Disclosures and Other Protected Action.  Nothing in this  Agreement shall be interpreted or applied to prohibit the Executive from making any good faith  report to any governmental agency or other governmental entity (a “Government Agency”)  concerning any act or omission that the Executive reasonably believes constitutes a possible  violation of federal or state law or making other disclosures that are protected under the anti- retaliation or whistleblower provisions of applicable federal or state law or regulation.  In  addition, nothing contained in this Agreement limits the Executive’s ability to communicate with  any Government Agency or otherwise participate in any investigation or proceeding that may be  conducted by any Government Agency, including the Executive’s ability to provide documents  or other information, without notice to the Company.  In addition, for the avoidance of doubt,  pursuant to the federal Defend Trade Secrets Act of 2016, the Executive shall not be held  criminally or civilly liable under any federal or state trade secret law or under this Agreement or  the Restrictive Covenants Agreement for the disclosure of a trade secret that (a) is made (i) in  confidence to a federal, state, or local government official, either directly or indirectly, or to an  attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law;  or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such  filing is made under seal.  9. Integration.  This Agreement constitutes the entire agreement between the parties  with respect to the subject matter hereof and supersedes all prior agreements between the parties  concerning such subject matter, including the Prior Agreement, provided that the Restrictive  Covenants Agreement and the Equity Documents remain in full force and effect.  10. Withholding; Tax Effect.  All payments made by the Company to the Executive  under this Agreement shall be net of any tax or other amounts required to be withheld by the  Company under applicable law.  Nothing in this Agreement shall be construed to require the  Company to make any payments to compensate the Executive for any adverse tax effect  associated with any payments or benefits or for any deduction or withholding from any payment  or benefit.    

 

   13    11. Assignment.  Neither the Executive nor the Company may make any assignment  of this Agreement or any interest in it, by operation of law or otherwise, without the prior written  consent of the other; provided, however, that the Company may assign its rights and obligations  under this Agreement (including the Restrictive Covenants Agreement) without the Executive’s  consent to any affiliate or to any person or entity with whom the Company shall hereafter effect  a reorganization, consolidate with, or merge into or to whom it transfers all or substantially all of  its properties or assets; provided further that if the purchaser in any transaction involving the  transfer of all or substantially all of the Company’s assets assumes this Agreement and the  Executive accepts a position with the purchaser that is equivalent or better to the Executive’s  position immediately preceding such transaction, then the Executive shall not be entitled to any  Severance Amount pursuant to Section 5 or any Change in Control Payment pursuant to Section  6.  This Agreement shall inure to the benefit of and be binding upon the Executive and the  Company, and each of the Executive’s and the Company’s respective successors, executors,  administrators, heirs and permitted assigns.    12. Enforceability.  If any portion or provision of this Agreement (including, without  limitation, any portion or provision of any section of this Agreement) shall to any extent be  declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this  Agreement, or the application of such portion or provision in circumstances other than those as  to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion  and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by  law.  13. Survival.  The provisions of this Agreement shall survive the termination of this  Agreement and/or the termination of the Executive’s employment to the extent necessary to  effectuate the terms contained herein.  14. Waiver.  No waiver of any provision hereof shall be effective unless made in  writing and signed by the waiving party.  The failure of any party to require the performance of  any term or obligation of this Agreement, or the waiver by any party of any breach of this  Agreement, shall not prevent any subsequent enforcement of such term or obligation or be  deemed a waiver of any subsequent breach.  15. Notices.  Any notices, requests, demands and other communications provided for  by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally  recognized overnight courier service or by registered or certified mail, postage prepaid, return  receipt requested, to the Executive at the last address the Executive has filed in writing with the  Company or, in the case of the Company, at its main offices, attention of the Board.  16. Amendment.  This Agreement may be amended or modified only by a written  instrument signed by the Executive and by a duly authorized representative of the Company.  17. Effect on Other Plans and Agreements.  An election by the Executive to resign for  Good Reason under the provisions of this Agreement shall not be deemed a voluntary  termination of employment by the Executive for the purpose of interpreting the provisions of any  of the Company's benefit plans, programs or policies.  Nothing in this Agreement shall be  construed to limit the rights of the Executive under the Company’s benefit plans, programs or  

 

   14    policies except as otherwise provided in Section 8 hereof, and except that the Executive shall  have no rights to any severance benefits under any Company severance pay plan, offer letter or  otherwise.  In the event that the Executive is party to an agreement with the Company providing  for payments or benefits under such agreement and this Agreement, the terms of this Agreement  shall govern and the Executive may receive payment under this Agreement only and not both.   Further, Section 5 and Section 6 of this Agreement are mutually exclusive and in no event shall  the Executive be entitled to payments or benefits pursuant to both Section 5 and Section 6 of this  Agreement.    18. Governing Law.  This is a New York contract and shall be construed under and be  governed in all respects by the laws of the State of New York, without giving effect to the  conflict of laws principles thereof.  With respect to any disputes concerning federal law, such  disputes shall be determined in accordance with the law as it would be interpreted and applied by  the United States Court of Appeals for the Second Circuit.  19. Counterparts.  This Agreement may be executed in any number of counterparts,  each of which when so executed and delivered shall be taken to be an original; but such  counterparts shall together constitute one and the same document.  IN WITNESS WHEREOF, the parties have executed this Agreement effective on the  “Effective Date.”  PHREESIA, INC.  By: /S/ Michael Weintraub   Its: Chairman, Board of Directors  EXECUTIVE:  /S/ Chaim Indig     Chaim Indig  

 

   Exhibit A  Restrictive Covenants Agreement    PHREESIA, INC.  Employee Confidentiality and Assignment Agreement  In consideration and as a condition of my employment or continued employment by Phreesia, Inc. (the  “Company”), I agree as follows:  1. Proprietary Information. I agree that all information, whether or not in writing, concerning the Company’s  business, technology, business relationships or financial affairs which the Company has not released to the general  public (collectively, “Proprietary Information”) is and will be the exclusive property of the Company. By way of  illustration, Proprietary Information may include information or material which has not been made generally  available to the public, such as: (a) corporate information, including plans, strategies, methods, policies, resolutions,  negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other  information about customers, prospect identities or other information about prospects, or market analyses or  projections; (c) financial information, including cost and performance data, debt arrangements, equity structure,  investors and holdings, purchasing and sales data and price lists; and (d) operational and technological  information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures,  formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information, including  personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance  evaluations and termination arrangements or documents. Proprietary Information also includes information received  in confidence by the Company from its customers or suppliers or other third parties.  2. Recognition of Company’s Rights. I will not, at any time, without the Company’s prior written permission,  either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or  use or permit to be used any Proprietary Information for any purpose other than the performance of my duties as an  employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized  disclosure of all Proprietary Information. I will deliver to the Company all copies of Proprietary Information in my  possession or control upon the earlier of a request by the Company or termination of my employment.  3. Rights of Others. I understand that the Company is now and may hereafter be subject to non-disclosure or  confidentiality agreements with third persons which require the Company to protect or refrain from use of  Proprietary Information. I agree to be bound by the terms of such agreements in the event I have access to such  Proprietary Information.  4. Commitment to Company; Avoidance of Conflict of Interest. While an employee of the Company, I will  devote my full-time efforts to the Company’s business and I will not engage in any other business activity that  conflicts with my duties to the Company. I will advise the president of the Company or his or her nominee at such  time as any activity of either the Company or another business presents me with a conflict of interest or the  appearance of a conflict of interest as an employee of the Company. I will take whatever action is requested of me  by the Company to resolve any conflict or appearance of conflict which it finds to exist.  5. Developments. I will make full and prompt disclosure to the Company of all inventions, discoveries, designs,  developments, methods, modifications, improvements, processes, algorithms, databases, computer programs,  formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship  (collectively “Developments”), whether or not patentable or copyrightable, that are created, made, conceived or  reduced to practice by me (alone or jointly with others) or under my direction during the period of my employment.  I acknowledge that all work performed by me is on a “work for hire” basis, and I hereby do assign and transfer and,  to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its  successors and assigns all my right, title and interest in all Developments that (a) relate to the business of the  Company or any customer of or supplier to the Company or any of the products or services being researched,  developed, manufactured or sold by the Company or which may be used with such products or services; or (b) result  from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether  tangible or intangible) owned, leased or contracted for by the Company (“Company-Related Developments”), and  

 

   16    all related patents, patent applications, trademarks and trademark applications, copyrights and copyright  applications, and other intellectual property rights in all countries and territories worldwide and under any  international conventions (“Intellectual Property Rights”).  This Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the  Company, reasonably exercised, is developed entirely on my own time and does not relate to the business efforts or  research and development efforts in which, during the period of my employment, the Company actually is engaged  or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the  Company. However, I will also promptly disclose to the Company any such Developments for the purpose of  determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be  construed in accordance with the laws of any state which precludes a requirement in an employee agreement to  assign certain classes of inventions made by an employee, this paragraph 5 will be interpreted not to apply to any  invention which a court rules and/or the Company agrees falls within such classes. I also hereby waive all claims to  any moral rights or other special rights which I may have or accrue in any Company-Related Developments.    6. Documents and Other Materials. I will keep and maintain adequate and current records of all Proprietary  Information and Company-Related Developments developed by me during my employment, which records will be  available to and remain the sole property of the Company at all times. All files, letters, notes, memoranda, reports,  records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, or other  written, photographic or other tangible material containing Proprietary Information, whether created by me or  others, which come into my custody or possession, are the exclusive property of the Company to be used by me only  in the performance of my duties for the Company. Any property situated on the Company’s premises and owned by  the Company, including without limitation computers, disks and other storage media, filing cabinets or other work  areas, is subject to inspection by the Company at any time with or without notice. In the event of the termination of  my employment for any reason, I will deliver to the Company all files, letters, notes, memoranda, reports, records,  data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, or other written,  photographic or other tangible material containing Proprietary Information, and other materials of any nature  pertaining to the Proprietary Information of the Company and to my work, and will not take or keep in my  possession any of the foregoing or any copies.  7. Enforcement of Intellectual Property Rights. I will cooperate fully with the Company, both during and after  my employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual  Property Rights in Company-Related Developments. I will sign, both during and after the term of this Agreement,  all papers, including without limitation copyright applications, patent applications, declarations, oaths, assignments  of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect  its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to  secure my signature on any such papers, I hereby irrevocably designate and appoint each officer of the Company as  my agent and attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the  Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related  Development.  8. Non-Competition and Non-Solicitation. In order to protect the Company’s Proprietary Information and good  will, during my employment and for a period of [twelve (12)] months following the termination of my employment  for any reason (the “Restricted Period”), I will not directly or indirectly, whether as owner, partner, shareholder,  director, consultant, agent, employee, co-venturer or otherwise, engage, participate or invest in any business activity  anywhere in the United States that develops, manufactures or markets any products, or performs any services, that  are otherwise competitive with or similar to the products or services of the Company, or products or services that the  Company has under development or that are the subject of active planning at any time during my employment;  provided that this shall not prohibit any possible investment in publicly traded stock of a company representing less  than one percent of the stock of such company. In addition, during the Restricted Period, I will not, directly or  indirectly, in any manner, other than for the benefit of the Company, (a) call upon, solicit, divert or take away any of  the customers, business or prospective customers of the Company or any of its suppliers, and/or (b) solicit, entice or  attempt to persuade any other employee or consultant of the Company to leave the services of the Company for any  reason. I acknowledge and agree that if I violate any of the provisions of this paragraph 8, the running of the  Restricted Period will be extended by the time during which I engage in such violation(s).  

 

   17    9. Prior Agreements. I hereby represent that, except as I have fully disclosed previously in writing to the Company,  I am not bound by the terms of any agreement with any previous employer or other party to refrain from using or  disclosing any trade secret or confidential or proprietary information in the course of my employment with the  Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any  other party. I further represent that my performance of all the terms of this Agreement as an employee of the  Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or  data acquired by me in confidence or in trust prior to my employment with the Company. I will not disclose to the  Company or induce the Company to use any confidential or proprietary information or material belonging to any  previous employer or others.  10. Remedies Upon Breach. I understand that the restrictions contained in this Agreement are necessary for the  protection of the business and goodwill of the Company and I consider them to be reasonable for such purpose. Any  breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the  event of such breach, the Company, in addition to such other remedies which may be available, will be entitled to  specific performance and other injunctive relief.  11. Publications and Public Statements. I will obtain the Company’s written approval before publishing or  submitting for publication any material that relates to my work at the Company and/or incorporates any Proprietary  Information. To ensure that the Company delivers a consistent message about its products, services and operations  to the public, and further in recognition that even positive statements may have a detrimental effect on the Company  in certain securities transactions and other contexts, any statement about the Company which I create, publish or  post during my period of employment and for six (6) months thereafter, on any media accessible by the public,  including but not limited to electronic bulletin boards and Internet-based chat rooms, must first be reviewed and  approved by an officer of the Company before it is released in the public domain.  12. No Employment Obligation. I understand that this Agreement does not create an obligation on the Company or  any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written  employment agreement signed on behalf of the Company by an authorized officer, my employment with the  Company is at will and therefore may be terminated by the Company or me at any time and for any reason.     13. Survival and Assignment by the Company. I understand that my obligations under this Agreement will  continue in accordance with its express terms regardless of any changes in my title, position, duties, salary,  compensation or benefits or other terms and conditions of employment. I further understand that my obligations  under this Agreement will continue following the termination of my employment regardless of the manner of such  termination and will be binding upon my heirs, executors and administrators. The Company will have the right to  assign this Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of  this Agreement for the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be  transferred without the necessity that this Agreement be resigned at the time of such transfer.  14. Disclosure to Future Employers. I will provide a copy of this Agreement to any prospective employer, partner  or coventurer prior to entering into an employment, partnership or other business relationship with such person or  entity.  15. Severability. In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be  held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the  other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable  provision had never been contained herein. If, moreover, any one or more of the provisions contained in this  Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or  subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the  applicable law as it shall then appear.  16. Interpretation. This Agreement will be deemed to be made and entered into in the State of New York, and will  in all respects be interpreted, enforced and governed under the laws of the State of New York. I hereby agree to  consent to personal jurisdiction of the state and federal courts situated within the State of New York for purposes of  enforcing this Agreement, and waive any objection that I might have to personal jurisdiction or venue in those  courts.  

 

   18    I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING  BELOW, I CERTIFY THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I  UNDERSTAND IT COMPLETELY.  IN WITNESS WHEREOF, the undersigned has executed this agreement as a sealed instrument as of the date  set forth below.     Signed:   /s/ Chaim Indig                (Employee’s full name)             Type or print name: Chaim Indig                Social Security Number:       Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]